Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China flag China · Delayed Price · Currency is CNY
170.00
-0.44 (-0.26%)
At close: Feb 6, 2026

SHA:600436 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,3471,4881,1592,4967,0975,168
Short-Term Investments
-3,5209,0146,202--
Trading Asset Securities
----8.80.01
Cash & Short-Term Investments
1,3475,00810,1738,6987,1065,168
Cash Growth
-58.80%-50.78%16.95%22.42%37.48%21.23%
Accounts Receivable
1,051894.431,021859.49673.3574.34
Other Receivables
67.4967.8865.15107.94134.9570.11
Receivables
1,119962.311,086967.43808.25644.45
Inventory
6,1604,9673,3792,6282,4382,191
Prepaid Expenses
-12.8214.054.5520.68-
Other Current Assets
2,073378.99447.9406.61261.36292.18
Total Current Assets
10,69911,32915,10012,70510,6338,296
Property, Plant & Equipment
1,7671,508614.62465.62400.14274.96
Long-Term Investments
1,347870.45631.98673.7799.87979.2
Other Intangible Assets
267.95273.1291.09319.37220.96259.38
Long-Term Deferred Tax Assets
141155.5187.31167.26166.9885.41
Long-Term Deferred Charges
30.134.0529.9937.6544.1949.42
Other Long-Term Assets
3,2263,370225.4235.41255.59261.16
Total Assets
17,47917,54017,08014,60412,52110,206
Accounts Payable
541.85480.01667.92464.9386.99239.94
Accrued Expenses
153.99485.41685.98345.39342.14139.24
Short-Term Debt
831.94892.79989.93970.96775.79718.38
Current Portion of Long-Term Debt
40.446.991.87---
Current Portion of Leases
-35.8131.8629.2122.75-
Current Income Taxes Payable
136.659.07142.6572.93108.9677.56
Current Unearned Revenue
182.88270.81237.1468.57326.56283.75
Other Current Liabilities
253.45142.92125.8158.22173.9341.46
Total Current Liabilities
2,1412,3742,8832,5102,1371,800
Long-Term Debt
56.0858.1535.44---
Long-Term Leases
130.48154.58107.29108.886.67-
Long-Term Unearned Revenue
26.0126.6817.6717.0120.2414.68
Pension & Post-Retirement Benefits
52.8453.2835.0434.2932.2329.42
Long-Term Deferred Tax Liabilities
0.220.3330.0261.0974.5247.47
Other Long-Term Liabilities
31.3134.151.3548.5432.8857.09
Total Liabilities
2,4382,7013,1602,7802,3841,949
Common Stock
603.32603.32603.32603.32603.32603.32
Additional Paid-In Capital
1,0951,0951,0951,0941,0861,085
Retained Earnings
12,68312,49711,6029,5597,8165,862
Comprehensive Income & Other
90.6876.9276.674.41200.05311.57
Total Common Equity
14,47214,27213,37611,3309,7057,862
Minority Interest
568.41567.01544.17493.97432.07394.39
Shareholders' Equity
15,04114,83913,92011,82410,1388,257
Total Liabilities & Equity
17,47917,54017,08014,60412,52110,206
Total Debt
1,0591,1481,1661,109885.21718.38
Net Cash (Debt)
288.093,8599,0077,5896,2204,450
Net Cash Growth
-86.26%-57.15%18.67%22.01%39.78%24.77%
Net Cash Per Share
0.486.3914.9412.5910.317.37
Filing Date Shares Outstanding
603.32603.32603.32603.32603.32603.32
Total Common Shares Outstanding
603.32603.32603.32603.32603.32603.32
Working Capital
8,5588,95512,21710,1958,4966,496
Book Value Per Share
23.9923.6622.1718.7816.0913.03
Tangible Book Value
14,20413,99913,08511,0119,4847,603
Tangible Book Value Per Share
23.5423.2021.6918.2515.7212.60
Buildings
-1,095400.13331.45332.55331.29
Machinery
-368.02345.33324.4300.25263.39
Construction In Progress
-314.85157.1960.7814.941.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.